Jefferies Financial Group Issues Pessimistic Forecast for Arteris (NASDAQ:AIP) Stock Price

Arteris (NASDAQ:AIP) had its target price decreased by Jefferies Financial Group from $50.00 to $40.00 in a report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group‘s target price suggests a potential upside of 124.72% from the stock’s previous close.

A number of other analysts have also weighed in on AIP. Oppenheimer started coverage on Arteris in a research note on Thursday, July 16th. They issued an “outperform” rating and a $40.00 target price on the stock. Weiss Ratings raised Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 21st. Roth Capital began coverage on shares of Arteris in a report on Tuesday, August 4th. They issued a “buy” rating and a $40.00 price target for the company. TD Cowen decreased their target price on Arteris from $40.00 to $25.00 and set a “buy” rating for the company in a report on Monday, October 19th. Finally, Craig Hallum assumed coverage on shares of Arteris in a report on Monday, September 21st. They set a “buy” rating and a $30.00 price target on the stock. Six research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $35.86.

Arteris Trading Up 11.7%

Shares of NASDAQ AIP traded up $1.87 during trading hours on Friday, hitting $17.80. 1,430,681 shares of the company traded hands, compared to its average volume of 720,131. The company’s 50 day moving average price is $21.51 and its 200 day moving average price is $24.94. Arteris has a 12 month low of $12.06 and a 12 month high of $50.26. The stock has a market capitalization of $874.91 million, a price-to-earnings ratio of -20.46 and a beta of 1.93. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.03.

Arteris (NASDAQ:AIP) last issued its quarterly earnings results on Thursday, November 5th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.02. Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%. The company had revenue of $25.77 million during the quarter, compared to the consensus estimate of $24.57 million. On average, equities research analysts anticipate that Arteris will post -0.68 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO K Janac sold 11,452 shares of Arteris stock in a transaction on Monday, October 5th. The stock was sold at an average price of $24.27, for a total value of $277,940.04. Following the completion of the transaction, the chief executive officer directly owned 154,337 shares in the company, valued at approximately $3,745,758.99. This trade represents a 6.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Paul Alpern sold 6,003 shares of Arteris stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $24.24, for a total value of $145,512.72. Following the completion of the transaction, the vice president owned 61,082 shares of the company’s stock, valued at $1,480,627.68. The trade was a 8.95% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 478,631 shares of company stock valued at $10,823,565 in the last three months. 23.30% of the stock is currently owned by insiders.

Institutional Trading of Arteris

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AIP. Sterling Capital Management LLC grew its holdings in shares of Arteris by 612.5% during the third quarter. Sterling Capital Management LLC now owns 1,197 shares of the company’s stock worth $28,000 after buying an additional 1,029 shares during the last quarter. Farther Finance Advisors LLC boosted its stake in shares of Arteris by 106.0% in the third quarter. Farther Finance Advisors LLC now owns 1,730 shares of the company’s stock valued at $41,000 after buying an additional 890 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of Arteris during the 2nd quarter worth $53,000. Versant Capital Management Inc grew its position in Arteris by 33.7% during the second quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock worth $56,000 after buying an additional 290 shares during the period. Finally, Royal Bank of Canada increased its stake in Arteris by 366.7% in the 1st quarter. Royal Bank of Canada now owns 4,023 shares of the company’s stock valued at $66,000 after purchasing an additional 3,161 shares in the last quarter. Institutional investors and hedge funds own 64.36% of the company’s stock.

Arteris News Roundup

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris reported Q3 revenue of $25.8 million, above the roughly $24.6 million consensus estimate. Its loss of $0.02 per share was narrower than analysts expected and improved from a $0.09 loss a year earlier. Arteris Q3 results and guidance
• Positive Sentiment: The company forecast Q4 revenue of $25.7 million to $26.7 million and FY2026 revenue of $98.5 million to $99.5 million. It also set a $103 million to $107 million target for annual contract value plus royalties, offering investors visibility into expected business activity. Arteris FY2026 forecast
• Positive Sentiment: Arteris surpassed 1,000 customer chip-design starts. The company says AI accounted for about half of its recent projects, pointing to potential demand from a fast-growing market. Arteris surpasses 1,000 customer design starts
• Negative Sentiment: Despite the improvement and estimate beat, Arteris remains loss-making, so investors may continue to watch its path toward profitability. Arteris Q3 loss and revenue results

Arteris Company Profile

Arteris, Inc is a semiconductor intellectual property (IP) company that provides technology used to design and integrate complex systems-on-chip (SoCs). Its products help semiconductor and system developers connect, manage and verify the various processing, memory and specialized functional components incorporated into modern chips.

The company’s portfolio includes network-on-chip (NoC) interconnect and semiconductor IP solutions, including its FlexNoC interconnect technology, Ncore cache-coherent interconnect IP and CodaCache products.